Donald Trump’s election to trigger new era of pharma mega-mergers

Following the US election outcome, analysts have come forward, claiming that a Trump presidency could open up a new era of mega-mergers for the pharmaceutical sector. Ketan Patel, a fund manager at EdenTree comments in The Telegraph.

Link

top